FDA Adverse Event Malfunction Summary report: N

APTIMA SARS COV-2

MDR report key: 14940434 · Received July 6, 2022

Report

Report Number
2024800-2022-01027
Event Type
Malfunction
Date Received
July 6, 2022
Date of Event
May 24, 2022
Report Date
July 6, 2022
Manufacturer
HOLOGIC, INC.
Product Code
OJR
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

OTHER.

Description of Event or Problem · 0

CUSTOMER REPORTED ONE SAMPLE TESTED WITH THE SARS-COV-2 ASSAY (ML 319638) ON THE PANTHER INSTRUMENT SN: (B)(4) HAD DISCREPANT RESULTS. INITIAL TEST IS NEGATIVE, AND RETEST IS POSITIVE. THIS WAS A VALIDATION SAMPLE. CUSTOMER USED A KNOWN POSITIVE AND NEGATIVE SAMPLE TESTED WITH THE THERMOFISHER-TAQPACH FOR THE VALIDATION. HOLOGIC TECHNICAL SUPPORT (TS) REVIEWED THE LOGS AND NOTED THAT THERE WAS NO INSTRUMENT HARDWARE ERROR OR REAGENT PREPARATION ISSUE. OTHER ASSAY RAN IN THE SAME INSTRUMENT COMPLETED WITHOUT ANY ISSUES. TS CONCLUDED THAT THE ISSUE WAS LIKELY DUE TO A LOW TARGET SAMPLE THAT DID NOT AMPLIFY THREE OF THE FOUR TIMES IT WAS TESTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2671099 APTIMA SARS COV-2 REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID OJR HOLOGIC, INC. 319638

Patients

Seq Age Sex Outcome Treatment
1 Unknown